An observational study in Renal Failure, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-11.
Sponsored by University of California, Davis · Observational
Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.
2,030 studies on the registry are indexed under Renal Insufficiency; 168 are open to participants now.
This study's enrollment of 797 is above the median of 150 across 398 observational studies indexed under Renal Insufficiency.
Browse Renal Insufficiency studies →University of California, Davis is the lead sponsor of 809 studies on the registry; 144 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 43 (64%) have results posted.
Counted across the registry records on this site, refreshed daily.
Renal transplant patients
Inclusion Criteria: Patients greater than or equal to 18 years old that underwent renal transplant at UC Davis Medical Center -
Exclusion Criteria: Patients that did not undergo renal transplants and patients less than 18 years old will be excluded from the study.
-
Cr/GFR improvement, postoperative mortality/morbidity (within 30 days) and overall complications
Time frame: 5 years
Graft failure, length of hospital stay (LOS), length of ICU stay, re-admission rate, infections, pulmonary complications.
Time frame: 5 years
length of intubation time, and length of ventilation time
Time frame: 5 years
Ran from Oct 2013 to primary completion in Feb 2020, 76 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis →